Marketing Safety Sustainability 
American Esthetician Organization
SEPTEMBER 13, 2023
But did you know that this lucrative market not only affects the world of pet products but also has a significant impact on the skincare industry ? In this article, we’ll delve into the fascinating connection between the pet industry and the skincare market, exploring the growth, trends, and influence they have on each other.
Kim Gallo Esthetics
FEBRUARY 27, 2024
The rise of transparency in ingredients, cruelty-free products, and sustainable packaging reflect not just our wish to appear youthful but our desire to live conscientiously. Recognizing skincare as a journey, not a race, is crucial for maintaining sustainable and lifelong skin health. Myth #2: Natural products are always better.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Dermatology Digest
FEBRUARY 18, 2025
It was very encouraging in the ReNeu trial to see that Gomekli provided deep and durable responses, with a manageable safety profile that enabled patients to stay on therapy. Gomekli demonstrated a manageable safety and tolerability profile.
The Dermatology Digest
FEBRUARY 10, 2025
Food and Drug Administration (FDA) and Marketing Authorization Application (MAA) in the UK and EU for CORDStrom in Recessive Dystrophic Epidermolysis Bullosa (RDEB). This trial showed a favorable benefit-risk profile in support of the intended applications for marketing authorization. INmune Bio, Inc.
Spa Executive
JULY 17, 2024
Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces. Another critical challenge is navigating the balance between sanitation and sustainability.
The Dermatology Digest
JULY 27, 2023
Patricia Farris discusses skincare industry trends, including consumer demand for “clean beauty,” sustainability, and resources for consumer and dermatologist ingredient education. So we just don’t have the standardization of what is being eliminated and no consensus as to what should be eliminated based on safety studies.
The Dermatology Digest
APRIL 23, 2024
The CRL did not identify any deficiencies related to the clinical efficacy or clinical safety data in the BLA, and the FDA did not request any new clinical trials or clinical data to support the approval of pz-cel. The BLA for pz-cel was accepted for filing and granted priority review designation by the FDA in November 2023.
Expert insights. Personalized for you.
164 
Let's personalize your content